Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001893119-21-000001
Filing Date
2021-11-12
Accepted
2021-11-12 14:09:46
Documents
1
Effectiveness Date
2021-11-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9264
  Complete submission text file 0001893119-21-000001.txt   10300
Mailing Address 1 KENDALL SQUARE, SUITE B200 CAMBRIDGE MA 02139
Business Address 1 KENDALL SQUARE, SUITE B200 CAMBRIDGE MA 02139 415-886-7710
Clade Therapeutics, Inc. (Filer) CIK: 0001893119 (see all company filings)

EIN.: 853881133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-420908 | Film No.: 211402522